- Home
- KBSX vs ANNX Comparison
KBSX vs ANNX Comparison
Compare KBSX & ANNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KBSX
- ANNX
- Stock Information
- Founded
- KBSX 1976
- ANNX 2011
- Country
- KBSX Taiwan
- ANNX United States
- Employees
- KBSX N/A
- ANNX N/A
- Industry
- KBSX Recreational Games/Products/Toys
- ANNX Biotechnology: Pharmaceutical Preparations
- Sector
- KBSX Consumer Discretionary
- ANNX Health Care
- Exchange
- KBSX Nasdaq
- ANNX Nasdaq
- Market Cap
- KBSX 299.4M
- ANNX 252.3M
- IPO Year
- KBSX N/A
- ANNX 2020
- Fundamental
- Price
- KBSX $1.79
- ANNX $2.45
- Analyst Decision
- KBSX
- ANNX Strong Buy
- Analyst Count
- KBSX 0
- ANNX 4
- Target Price
- KBSX N/A
- ANNX $12.50
- AVG Volume (30 Days)
- KBSX 1.1M
- ANNX 1.4M
- Earning Date
- KBSX 05-16-2025
- ANNX 08-11-2025
- Dividend Yield
- KBSX N/A
- ANNX N/A
- EPS Growth
- KBSX N/A
- ANNX N/A
- EPS
- KBSX N/A
- ANNX N/A
- Revenue
- KBSX $36,499,644.00
- ANNX N/A
- Revenue This Year
- KBSX N/A
- ANNX N/A
- Revenue Next Year
- KBSX N/A
- ANNX N/A
- P/E Ratio
- KBSX N/A
- ANNX N/A
- Revenue Growth
- KBSX 27.04
- ANNX N/A
- 52 Week Low
- KBSX $1.26
- ANNX $1.29
- 52 Week High
- KBSX $15.48
- ANNX $7.85
- Technical
- Relative Strength Index (RSI)
- KBSX N/A
- ANNX 57.01
- Support Level
- KBSX N/A
- ANNX $2.25
- Resistance Level
- KBSX N/A
- ANNX $2.81
- Average True Range (ATR)
- KBSX 0.00
- ANNX 0.19
- MACD
- KBSX 0.00
- ANNX -0.03
- Stochastic Oscillator
- KBSX 0.00
- ANNX 35.09
About KBSX FST Corp. Ordinary Shares
FST Corp is a renowned manufacturer and innovator in the golf industry with a growing portfolio of creative golf products, including acclaimed golf club shafts and other equipment. The Company has engaged in the research, development, manufacturing, and sales of golf club shafts. The Company currently produces and sells golf club shafts under the Company's own high-performance KBS golf club shaft brand, and serves as an original equipment manufacturer (OEM) and original design manufacturer (ODM) for other world-renowned golf equipment brands, golf equipment OEMs, and golf equipment distributors that provide consumers with customized golf club services.
About ANNX Annexon Inc.
Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502 for Oral small molecule; and ANX009, for systemic autoimmune diseases.